CARGO Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma (NCT05972720) | CARGO Therapeutics | 2023-08-01 |
Track CARGO Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.